Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $537,913 - $616,951
4,008 New
4,008 $538,000
Q3 2021

Nov 16, 2021

BUY
$106.4 - $120.78 $374,528 - $425,145
3,520 Added 20705.88%
3,537 $382,000
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $1,788 - $1,992
17 New
17 $2,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mint Tower Capital Management B.V. Portfolio

Follow Mint Tower Capital Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mint Tower Capital Management B.V. with notifications on news.